Anzeige
Mehr »
Login
Dienstag, 07.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Diese Aktie hebt ab: +130,67% Kursgewinn in 1 Monat – das sind die Gründe
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
99 Leser
Artikel bewerten:
(0)

FDA Seeks Court Order Against Michigan Dairy / Government alleges cattle sold for human consumption contained illegal drug residues

SILVER SPRING, Md., Aug. 31 /PRNewswire-USNewswire/ -- The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, has filed a complaint for permanent injunction against Scenic View Dairy of Hamilton, Mich., its president, and three of its managers alleging that they sold dairy cows for human consumption that contained illegal drug residues in edible tissues.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

The complaint, filed August 31, 2010 in the U.S. District Court for the Western District of Michigan, also alleges that the defendants, despite numerous warnings, sold for slaughter dairy cows that were treated with drugs contrary to the drugs' FDA-approved labeling and without a valid veterinary prescription authorizing such use.

The complaint alleges that violations occurred from 2002 through 2010 at Scenic View Dairy's three farms, located in Fennville, Freeport, and Gowen, Mich. Company president Michael D. Geerlings, Fennville farm manager Mark A. Lucas, Freeport farm manager Michael J. Van Dam, and Gowen farm manager Jeremy A. Portell were all named in the complaint.

Between 2001 and 2010, the FDA notified the defendants of its inspectional findings on at least eight occasions, and USDA sent Scenic View at least 11 letters regarding illegal tissue residues. The complaint alleges that the defendants continue to violate the law despite these warnings.

The complaint is based, in part, upon illegal neomycin, penicillin, and sulfadimethoxine drug residues that the USDA found in the edible tissue of dairy cows that defendants had offered for sale for human consumption.

Neomycin, penicillin, and sulfadimethoxine are antibiotics. The sale of animals for human food that contain illegal levels of drugs can lead to the development of bacteria that resist antibiotics and can cause reactions in people with drug allergies. FDA regulations for animal drugs include a specified time to withdraw an animal from treatment prior to slaughter so that a drug is depleted from edible tissue to levels safe for humans.

Scenic View Dairy buys cows primarily from New Hampshire, Pennsylvania and Vermont and sells to slaughterhouses in other states, including Pennsylvania and Wisconsin.

For more information: Inspections, Compliance, Enforcement, and Criminal Investigations http://www.fda.gov/ICECI/default.htm

FDA Issues Draft Guidance on the Judicious Use of Medically Important Antimicrobials in Food-Producing Animals

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm217464.htm Media Inquiries: Siobhan DeLancey, 301-796-4668, siobhan.delancey@fda.hhs.gov or Ira Allen, 301-796-5349, ira.allen@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA

Photo: PRN Photo Desk, photodesk@prnewswire.com
http://photos.prnewswire.com/prnh/20090824/FDALOGO

U.S. Food and Drug Administration

CONTACT: Siobhan DeLancey, +1-301-796-4668, siobhan.delancey@fda.hhs.gov
or Ira Allen, 301-796-5349, ira.allen@fda.hhs.gov, both of the U.S. Food and
Drug Administration

Web Site: http://www.fda.gov/

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2010 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.